Dr. Margalit is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-3591
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2007 - 2011
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2006 - 2010
- Brigham and Women's HospitalResidency, Internal Medicine, 2006 - 2007
- Harvard Medical SchoolClass of 2006
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- MA State Medical License 2008 - 2026
- ME State Medical License 2020 - 2025
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer Start of enrollment: 2013 Feb 01
- Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma Start of enrollment: 2019 May 20
Publications & Presentations
PubMed
- Prospective Trial of Biomarker-Guided Surveillance for HPV-positive Oropharynx Cancer Using Plasma Tumor Tissue Modified Viral HPV DNA.Eleni M Rettig, Jonathan D Schoenfeld, Julianna Miller, Bethany Sargent, Evan Carey
Clinical Cancer Research. 2024-12-26 - Changes in Merkel cell oncoprotein antibodies after radiation therapy in curatively treated Merkel cell carcinoma and association with recurrence.Kevin X Liu, Kee-Young Shin, Manisha Thakuria, Jonathan D Schoenfeld, Roy B Tishler
Cancer. 2024-12-15 - 5 citationsPersonalized ctDNA for Monitoring Disease Status in Head and Neck Squamous Cell Carcinoma.Glenn J Hanna, Michael J Dennis, Nicole Scarfo, Michelle S Mullin, Rosh K V Sethi
Clinical Cancer Research. 2024-08-01
Press Mentions
- Trial “Informs Practice Tremendously” for Low-Risk HPV-Oropharyngeal CancerOctober 8th, 2024
- Standard Chemoradiation Remains Superior for HPV-Associated Oropharyngeal CancerOctober 4th, 2024
- High Rates of Oropharynx Cancer Tied to HPVSeptember 11th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: